Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Clin Cancer Res. 2011 Feb 23;17(7):2024–2034. doi: 10.1158/1078-0432.CCR-10-2567

Fig. 6.

Fig. 6

MYC is required for hormone-independent cell proliferation. Cells transfected with siRNA targeting MYC or non-silencing control (siCtl) were treated with 10% DCC-FBS, and adherent cells were counted after 6 days. Data are presented as % siCtl, mean of triplicates ± SD. *p<0.01 by t-test compared to siCtl. B) MYC and actin immunoblots of lysates from the same batches of cells used in (A).